• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消化链球菌属对大环内酯类和林可酰胺类的耐药性:诱导型和组成型表型

Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

作者信息

Reig M, Moreno A, Baquero F

机构信息

Servicio de Microbiología, Hospital Ramón y Cajal, Instituto Nacional de la Salud, Madrid, Spain.

出版信息

Antimicrob Agents Chemother. 1992 Mar;36(3):662-4. doi: 10.1128/AAC.36.3.662.

DOI:10.1128/AAC.36.3.662
PMID:1622181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190575/
Abstract

The activities of erythromycin and clindamycin against 350 Peptostreptococcus strains were studied during a 5-year period (1986 to 1991). In 5.1% of the Peptostreptococcus strains, which presented dissociated resistance (clindamycin MIC, less than or equal to 1 microgram/ml; erythromycin MIC, greater than 8 micrograms/ml), evidence of inducible macrolide-lincosamide resistance was shown. A total of 17.7% of the strains presented a constitutive phenotype; the clindamycin and erythromycin MICs for these strains were greater than 8 micrograms/ml.

摘要

在1986年至1991年的5年期间,研究了红霉素和克林霉素对350株消化链球菌菌株的活性。在5.1%呈现解离耐药性(克林霉素MIC≤1微克/毫升;红霉素MIC>8微克/毫升)的消化链球菌菌株中,显示出诱导型大环内酯 - 林可酰胺耐药性的证据。共有17.7%的菌株呈现组成型表型;这些菌株的克林霉素和红霉素MIC均大于8微克/毫升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd7/190575/72f1f21f0bd2/aac00037-0189-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd7/190575/72f1f21f0bd2/aac00037-0189-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd7/190575/72f1f21f0bd2/aac00037-0189-a.jpg

相似文献

1
Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.消化链球菌属对大环内酯类和林可酰胺类的耐药性:诱导型和组成型表型
Antimicrob Agents Chemother. 1992 Mar;36(3):662-4. doi: 10.1128/AAC.36.3.662.
2
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.意大利耐红霉素化脓性链球菌菌株的表型和基因型以及诱导性耐药菌株的异质性
Antimicrob Agents Chemother. 1999 Aug;43(8):1935-40. doi: 10.1128/AAC.43.8.1935.
3
Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.耐红霉素肺炎球菌耐药表型的鉴别
J Clin Microbiol. 2001 Apr;39(4):1311-5. doi: 10.1128/JCM.39.4.1311-1315.2001.
4
Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.从波士顿地区患者中检测出多种对大环内酯类和林可酰胺类耐药的化脓性链球菌菌株。
J Clin Microbiol. 2004 Apr;42(4):1559-63. doi: 10.1128/JCM.42.4.1559-1563.2004.
5
Disc diffusion method to screen for high-level resistance to clindamycin and erythromycin in the Bacteroides fragilis group.纸片扩散法筛选脆弱拟杆菌属中对克林霉素和红霉素的高水平耐药性
Diagn Microbiol Infect Dis. 1985 Mar;3(2):131-7. doi: 10.1016/0732-8893(85)90022-7.
6
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.对具有诱导型或组成型大环内酯-林可酰胺-链阳菌素B耐药性的化脓性链球菌有效的新型大环内酯类药物。
Antimicrob Agents Chemother. 1989 Jan;33(1):78-81. doi: 10.1128/AAC.33.1.78.
7
Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species.拟杆菌属中可诱导的大环内酯类-林可酰胺类-链阳菌素B耐药性
Antimicrob Agents Chemother. 1987 Apr;31(4):665-6. doi: 10.1128/AAC.31.4.665.
8
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.新型酮内酯类药物泰利霉素与大环内酯类药物对化脓性链球菌的体外活性比较:耐药机制和方法学因素的影响
Antimicrob Agents Chemother. 2000 Nov;44(11):2999-3002. doi: 10.1128/AAC.44.11.2999-3002.2000.
9
[Macrolide resistance phenotypes and genotypes in group G streptococci].G组链球菌中的大环内酯类耐药表型与基因型
Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):117-24.
10
Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.希腊雅典一家三级护理医院葡萄球菌中大环内酯类、林可酰胺类和链阳菌素耐药性的流行情况
J Chemother. 2015;27(6):319-23. doi: 10.1179/1973947814Y.0000000205. Epub 2014 Aug 11.

引用本文的文献

1
In Vitro Antimicrobial Susceptibility Profiles of Gram-Positive Anaerobic Cocci Responsible for Human Invasive Infections.引起人类侵袭性感染的革兰氏阳性厌氧球菌的体外抗菌药敏谱
Microorganisms. 2021 Aug 4;9(8):1665. doi: 10.3390/microorganisms9081665.
2
Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.由ermTR介导的消化链球菌属对大环内酯类的耐药性:化脓性链球菌中可能的大环内酯-林可酰胺-链阳菌素B耐药性来源。
Antimicrob Agents Chemother. 2001 Feb;45(2):630-2. doi: 10.1128/AAC.45.2.630-632.2001.
3
Gram-positive anaerobic cocci.

本文引用的文献

1
Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.来自法国几家医院的厌氧菌对三种主要抗生素的敏感性
Antimicrob Agents Chemother. 1984 Jun;25(6):764-6. doi: 10.1128/AAC.25.6.764.
2
The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression.红霉素抗性的控制区域:与诱导及组成型表达突变相关的自由能变化
Mol Gen Genet. 1981;182(2):341-8. doi: 10.1007/BF00269681.
3
Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction.
革兰氏阳性厌氧球菌
Clin Microbiol Rev. 1998 Jan;11(1):81-120. doi: 10.1128/CMR.11.1.81.
4
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.二氧化碳对厌氧菌对红霉素、阿奇霉素、克拉霉素和罗红霉素敏感性的影响。
Antimicrob Agents Chemother. 1994 Feb;38(2):211-6. doi: 10.1128/AAC.38.2.211.
5
Resistance of anaerobic bacteria to antimicrobial agents in Spain.西班牙厌氧菌对抗菌药物的耐药性
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1016-20. doi: 10.1007/BF01967792.
金黄色葡萄球菌中红霉素诱导性耐药:诱导的条件
J Bacteriol. 1971 Jun;106(3):835-47. doi: 10.1128/jb.106.3.835-847.1971.
4
Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.从女性生殖道感染中分离出的厌氧菌的药敏性
Antimicrob Agents Chemother. 1985 Mar;27(3):324-31. doi: 10.1128/AAC.27.3.324.
5
Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy.从克林霉素治疗后采集的培养物中分离出耐克林霉素厌氧菌的情况。
Antimicrob Agents Chemother. 1986 Jul;30(1):11-4. doi: 10.1128/AAC.30.1.11.
6
In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.头孢美唑、头孢替坦、阿莫西林-克拉维酸及其他抗菌药物对盆腔感染女性子宫内膜培养物中厌氧菌的体外活性。
Antimicrob Agents Chemother. 1987 Sep;31(9):1434-7. doi: 10.1128/AAC.31.9.1434.
7
In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.头孢哌酮加舒巴坦与其他抗菌药物对厌氧菌的体外活性比较。
Antimicrob Agents Chemother. 1988 Mar;32(3):403-6. doi: 10.1128/AAC.32.3.403.
8
Susceptibility of anaerobic bacteria to FCE 22101.厌氧菌对FCE 22101的敏感性。
Antimicrob Agents Chemother. 1987 May;31(5):831-3. doi: 10.1128/AAC.31.5.831.
9
Selection of constitutively resistant mutants of inducible clindamycin-resistant Bacteroides vulgatus.诱导性耐克林霉素的脆弱拟杆菌组成型抗性突变体的筛选
Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):711-5. doi: 10.1007/BF01963757.
10
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.厌氧菌对23种抗菌剂的敏感性。
Antimicrob Agents Chemother. 1976 Oct;10(4):736-52. doi: 10.1128/AAC.10.4.736.